Emory University/Winship Cancer Center

Atlanta, Georgia 30322-1013

2 studies enrolling now · 7 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Graft Vs Host Disease, Graft vs Host Disease, Malignancy, Mixed Phenotype Acute Leukemia, Non-hodgkin's Lymphoma, Non-small Cell Lung Cancer, Relapsed/Refractory Multiple Myeloma, Renal Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity

Studies at this site

• A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma — Recruiting now
• Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis — Recruiting now
• Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL — Recruiting now
• Abatacept as GVHD Prophylaxis Phase 2 — Completed
• VIC-1911 Monotherapy in Combination With Sotorasib for the Treatment of KRAS G12C-Mutant Non-Small Cell Lung Cancer — Stopped early
• IRX-2 Regimen in Patients With Newly Diagnosed Stage II, III, or IVA Squamous Cell Carcinoma of the Oral Cavity — Completed
• Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) — Completed